A number of firms have modified their ratings and price targets on shares of Allstate (NYSE: ALL) recently:
- 11/8/2024 – Allstate had its price target raised by analysts at Jefferies Financial Group Inc. from $231.00 to $267.00. They now have a “buy” rating on the stock.
- 11/7/2024 – Allstate had its price target raised by analysts at Morgan Stanley from $220.00 to $228.00. They now have an “overweight” rating on the stock.
- 11/6/2024 – Allstate had its price target raised by analysts at Keefe, Bruyette & Woods from $222.00 to $225.00. They now have an “outperform” rating on the stock.
- 11/5/2024 – Allstate had its price target raised by analysts at Wells Fargo & Company from $175.00 to $186.00. They now have an “equal weight” rating on the stock.
- 11/4/2024 – Allstate had its price target raised by analysts at UBS Group AG from $216.00 to $225.00. They now have a “buy” rating on the stock.
- 10/31/2024 – Allstate had its price target raised by analysts at Barclays PLC from $175.00 to $187.00. They now have an “underweight” rating on the stock.
- 10/21/2024 – Allstate had its price target raised by analysts at Morgan Stanley from $202.00 to $215.00. They now have an “overweight” rating on the stock.
- 10/18/2024 – Allstate had its price target raised by analysts at BMO Capital Markets from $205.00 to $214.00. They now have an “outperform” rating on the stock.
- 10/18/2024 – Allstate had its price target raised by analysts at Bank of America Co. from $216.00 to $233.00. They now have a “buy” rating on the stock.
- 10/15/2024 – Allstate had its price target raised by analysts at UBS Group AG from $215.00 to $216.00. They now have a “buy” rating on the stock.
- 10/10/2024 – Allstate had its price target raised by analysts at JPMorgan Chase & Co. from $205.00 to $207.00. They now have an “overweight” rating on the stock.
- 10/10/2024 – Allstate had its price target lowered by analysts at Bank of America Co. from $226.00 to $216.00. They now have a “buy” rating on the stock.
- 10/9/2024 – Allstate had its price target raised by analysts at Evercore ISI from $191.00 to $195.00. They now have an “in-line” rating on the stock.
- 10/9/2024 – Allstate had its price target raised by analysts at Jefferies Financial Group Inc. from $217.00 to $231.00. They now have a “buy” rating on the stock.
- 10/4/2024 – Allstate had its price target raised by analysts at Raymond James from $205.00 to $220.00. They now have a “strong-buy” rating on the stock.
Allstate Price Performance
Shares of NYSE ALL traded down $1.19 during mid-day trading on Thursday, hitting $196.11. 226,205 shares of the company’s stock traded hands, compared to its average volume of 1,539,748. The company has a market capitalization of $51.93 billion, a P/E ratio of 12.70, a PEG ratio of 1.77 and a beta of 0.48. The Allstate Co. has a 1 year low of $130.77 and a 1 year high of $201.00. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.40 and a quick ratio of 0.40. The company’s 50-day moving average is $189.58 and its two-hundred day moving average is $176.40.
Allstate (NYSE:ALL – Get Free Report) last announced its earnings results on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, topping analysts’ consensus estimates of $2.20 by $1.71. The firm had revenue of $16.63 billion during the quarter, compared to analysts’ expectations of $14.57 billion. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The company’s quarterly revenue was up 14.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.81 EPS. On average, equities analysts anticipate that The Allstate Co. will post 16.02 EPS for the current fiscal year.
Allstate Announces Dividend
Insider Transactions at Allstate
In other news, EVP Elizabeth Brady sold 49,481 shares of the business’s stock in a transaction on Friday, August 16th. The shares were sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the completion of the sale, the executive vice president now directly owns 19,163 shares of the company’s stock, valued at approximately $3,431,901.67. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other Allstate news, EVP Robert Toohey sold 16,682 shares of Allstate stock in a transaction on Monday, August 19th. The stock was sold at an average price of $180.17, for a total transaction of $3,005,595.94. Following the completion of the sale, the executive vice president now directly owns 4,873 shares of the company’s stock, valued at $877,968.41. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Elizabeth Brady sold 49,481 shares of the stock in a transaction on Friday, August 16th. The stock was sold at an average price of $179.09, for a total value of $8,861,552.29. Following the transaction, the executive vice president now directly owns 19,163 shares in the company, valued at $3,431,901.67. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 192,530 shares of company stock worth $34,967,665. 1.80% of the stock is currently owned by company insiders.
Institutional Trading of Allstate
A number of hedge funds have recently added to or reduced their stakes in ALL. Pathway Financial Advisers LLC boosted its position in Allstate by 18,472.5% during the 3rd quarter. Pathway Financial Advisers LLC now owns 1,052,687 shares of the insurance provider’s stock valued at $199,642,000 after acquiring an additional 1,047,019 shares in the last quarter. Allspring Global Investments Holdings LLC grew its holdings in Allstate by 18.7% during the third quarter. Allspring Global Investments Holdings LLC now owns 3,000,866 shares of the insurance provider’s stock worth $569,114,000 after acquiring an additional 472,040 shares during the period. AQR Capital Management LLC raised its position in Allstate by 181.6% during the second quarter. AQR Capital Management LLC now owns 719,997 shares of the insurance provider’s stock valued at $114,955,000 after acquiring an additional 464,337 shares in the last quarter. TimesSquare Capital Management LLC purchased a new stake in Allstate in the 3rd quarter worth approximately $77,819,000. Finally, Acadian Asset Management LLC boosted its position in Allstate by 3,839.0% in the 2nd quarter. Acadian Asset Management LLC now owns 416,117 shares of the insurance provider’s stock worth $66,417,000 after purchasing an additional 405,553 shares in the last quarter. 76.47% of the stock is owned by hedge funds and other institutional investors.
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Stories
- Five stocks we like better than Allstate
- Roth IRA Calculator: Calculate Your Potential Returns
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- How to buy stock: A step-by-step guide for beginners
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- Market Cap Calculator: How to Calculate Market Cap
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for The Allstate Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Allstate Co and related companies with MarketBeat.com's FREE daily email newsletter.